The global ventricular assist devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of heart failure and the rising number of patients with end-stage heart disease. The increasing incidence of cardiovascular diseases in developing countries such as India and China is also expected to fuel the growth of this market during the forecast period. The right ventricular assist devices (RVAD) segment accounted for a share of over 50% in 2017, owing to its higher adoption rate among hospitals and cardiology centers for treating patients with end-stage heart disease. The left ventricular assist devices (LVAD) segment accounted for a share close to 30% in 2017, owing to its higher adoption rate among ambulatory surgical centers and cardiology centers for treating patients with end-stage heart disease. -The VAD market is expected to grow at a CAGR of 5.5% from 2017 to 2022, reaching $2.6 billion by 2022. -The VAD market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in medical devices. -Increasing prevalence of chronic diseases such as diabetes mellitus and hypertension has led to an increase in the number of patients suffering from cardiovascular disease which has increased the demand for VADs globally. -Technological advancements have led to improved design and performance of VADs which has increased their adoption rates among physicians.
Industry Growth Insights published a new data on “Ventricular Assist Devices Market”. The research report is titled “Ventricular Assist Devices Market research by Types (Right Ventricular Assist Devices (RVAD), Left Ventricular Assist Devices (LVAD), Bipolar Ventricular Assist Devices (BVAD)), By Applications (Hospitals, Ambulatory Surgical Centers, Cardiology Centers), By Players/Companies Abiomed, Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, Berlin Heart, ReliantHeart, HeartWare International, Jarvik Heart, St. Jude Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ventricular Assist Devices Market Research Report
By Type
Right Ventricular Assist Devices (RVAD), Left Ventricular Assist Devices (LVAD), Bipolar Ventricular Assist Devices (BVAD)
By Application
Hospitals, Ambulatory Surgical Centers, Cardiology Centers
By Companies
Abiomed, Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, Berlin Heart, ReliantHeart, HeartWare International, Jarvik Heart, St. Jude Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Ventricular Assist Devices Market Report Segments:
The global Ventricular Assist Devices market is segmented on the basis of:
Types
Right Ventricular Assist Devices (RVAD), Left Ventricular Assist Devices (LVAD), Bipolar Ventricular Assist Devices (BVAD)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Cardiology Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abiomed
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- LivaNova PLC
- Medtronic plc
- Berlin Heart
- ReliantHeart
- HeartWare International
- Jarvik Heart
- St. Jude Medical
Highlights of The Ventricular Assist Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Right Ventricular Assist Devices (RVAD)
- Left Ventricular Assist Devices (LVAD)
- Bipolar Ventricular Assist Devices (BVAD)
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Cardiology Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ventricular Assist Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A ventricular assist device (VAD) is a medical device that helps to maintain blood flow in the brain. It is used when there is a lack of blood flow due to an illness or injury. VADs can help improve the quality of life for people who have suffered a stroke or other brain injury.
Some of the major players in the ventricular assist devices market are Abiomed, Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, Berlin Heart, ReliantHeart, HeartWare International, Jarvik Heart, St. Jude Medical.
The ventricular assist devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ventricular Assist Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ventricular Assist Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ventricular Assist Devices Market - Supply Chain
4.5. Global Ventricular Assist Devices Market Forecast
4.5.1. Ventricular Assist Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ventricular Assist Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ventricular Assist Devices Market Absolute $ Opportunity
5. Global Ventricular Assist Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ventricular Assist Devices Market Size and Volume Forecast by Type
5.3.1. Right Ventricular Assist Devices (RVAD)
5.3.2. Left Ventricular Assist Devices (LVAD)
5.3.3. Bipolar Ventricular Assist Devices (BVAD)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ventricular Assist Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ventricular Assist Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Cardiology Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ventricular Assist Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ventricular Assist Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ventricular Assist Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ventricular Assist Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ventricular Assist Devices Demand Share Forecast, 2019-2026
9. North America Ventricular Assist Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ventricular Assist Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ventricular Assist Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Cardiology Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ventricular Assist Devices Market Size and Volume Forecast by Type
9.7.1. Right Ventricular Assist Devices (RVAD)
9.7.2. Left Ventricular Assist Devices (LVAD)
9.7.3. Bipolar Ventricular Assist Devices (BVAD)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ventricular Assist Devices Demand Share Forecast, 2019-2026
10. Latin America Ventricular Assist Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ventricular Assist Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ventricular Assist Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Cardiology Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ventricular Assist Devices Market Size and Volume Forecast by Type
10.7.1. Right Ventricular Assist Devices (RVAD)
10.7.2. Left Ventricular Assist Devices (LVAD)
10.7.3. Bipolar Ventricular Assist Devices (BVAD)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ventricular Assist Devices Demand Share Forecast, 2019-2026
11. Europe Ventricular Assist Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ventricular Assist Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ventricular Assist Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Cardiology Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ventricular Assist Devices Market Size and Volume Forecast by Type
11.7.1. Right Ventricular Assist Devices (RVAD)
11.7.2. Left Ventricular Assist Devices (LVAD)
1.7.3. Bipolar Ventricular Assist Devices (BVAD)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ventricular Assist Devices Demand Share, 2019-2026
12. Asia Pacific Ventricular Assist Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ventricular Assist Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ventricular Assist Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Cardiology Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ventricular Assist Devices Market Size and Volume Forecast by Type
12.7.1. Right Ventricular Assist Devices (RVAD)
12.7.2. Left Ventricular Assist Devices (LVAD)
12.7.3. Bipolar Ventricular Assist Devices (BVAD)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ventricular Assist Devices Demand Share, 2019-2026
13. Middle East & Africa Ventricular Assist Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ventricular Assist Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ventricular Assist Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Cardiology Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ventricular Assist Devices Market Size and Volume Forecast by Type
13.7.1. Right Ventricular Assist Devices (RVAD)
13.7.2. Left Ventricular Assist Devices (LVAD)
13.7.3. Bipolar Ventricular Assist Devices (BVAD)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ventricular Assist Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ventricular Assist Devices Market: Market Share Analysis
14.2. Ventricular Assist Devices Distributors and Customers
14.3. Ventricular Assist Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abiomed
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Biotronik SE & Co. KG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. LivaNova PLC
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medtronic plc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Berlin Heart
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ReliantHeart
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. HeartWare International
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Jarvik Heart
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. St. Jude Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook